Skip to main content

Advertisement

Table 1 Detection of Panels 6272 and 11,000 by Serological Assays

From: Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors

Assay First Positive Panel Member
Panel 6272 Panel 11,000
Panel Member Day Panel Member Day
ARCHITECT HBsAg Prototype 12 51 1 0
PreS2 Research Assay 16 65 4 14
ARCHITECT HBsAg Qual. II 20 94 6 21
Elecsys HBsAg II 20 94 6 21
LIAISON XL MUREX HBsAg Quant. 20a 94 6b 21
Lumipulse HBcrAg 21c 97 6d 21
Centaur HBsAg II 21 97 6 21
  1. The ARCHITECT Prototype, PreS2, ARCHITECT Qual.II, Elecsys, and Centaur assays are qualitative; the LIAISON and Lumipulse assays are quantitative
  2. a0.08 IU/ml HBsAg, b0.05 IU/ml HBsAg, c3 U/ml HBcrAg, d3.1 U/ml HBcrAg